The impact of mixed etiology in community acquired pneumonia (CAP)

B. Montull, R. Menendez, R. Mendez, T. Torres, S. Reyes, R. Zalacain, A. Capelastegui, J. Aspa, L. Borderias, J. Martin-Villasclaras, S. Bello, I. Alfageme, F. Rodriguez-de-Castro, J. Rello, L. Molinos, J. Ruiz-Manzano, NAC CALIDAD Group (Valencia, Barcelona, Vizcaya, Madrid, Huesca, Málaga, Zaragoza, Sevilla, Las Palmas, Oviedo, Badalona, Spain)

Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Session: Respiratory infections: inflammation and treatment
Session type: Oral Presentation
Number: 4649
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Montull, R. Menendez, R. Mendez, T. Torres, S. Reyes, R. Zalacain, A. Capelastegui, J. Aspa, L. Borderias, J. Martin-Villasclaras, S. Bello, I. Alfageme, F. Rodriguez-de-Castro, J. Rello, L. Molinos, J. Ruiz-Manzano, NAC CALIDAD Group (Valencia, Barcelona, Vizcaya, Madrid, Huesca, Málaga, Zaragoza, Sevilla, Las Palmas, Oviedo, Badalona, Spain). The impact of mixed etiology in community acquired pneumonia (CAP). Eur Respir J 2014; 44: Suppl. 58, 4649

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors affecting treatment success in community acquired pneumonia (CAP)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Bacteremia in non-HIV community acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Common organisms causing community acquired pneumonia
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Community acquired lung respiratory infections in HIV-infected patients: Microbial etiology and outcome
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Relationship between bacterial sensivity pattern and hospital antibiotic consumption,in patients with community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Clinical judgement on top of CURB65-score in predicting 30 days clinical outcome in patients with community acquired pneumonia (CAP) admitted to the hospital
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Immunoglobulin levels and severity of community-acquired pneumonia (CAP)
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013

Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013


The prevalence of cardiac diseases in patients with community-acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Community adquired legionella pneumophila pneumonia in elderly patients
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014